Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
June—Asuragen Inc.
(diagnostics and pharmaceutical services) has licensed
non-exclusive rights to Johns Hopkins University's BRAF V600E mutation sequence for use in
molecular diagnostics for cancer.
BRAF mutation has been used as a genetic marker for various cancer types. JHU has found that detection of the...